Cited by 43Treatment of Major DepressionElectroconvulsive Therapy StudiesAnesthesia and Sedative Agents

Exploring Nitrous Oxide as Treatment of Mood Disorders: Basic Concepts

Open access
Nagele, Peter, Zorumski, Charles F., Conway, Charles·2018·Journal of Clinical Psychopharmacology

Abstract

Nitrous oxide (laughing gas) has shown early promise as a rapidly acting antidepressant in patients with treatment-resistant major depression and is currently investigated in several clinical trials. Because nitrous oxide is rarely administered outside operating rooms or dental practices, most psychiatrists are not familiar with how nitrous oxide is administered in a medical setting and what regulations guide its use. The goal of this brief review was to educate psychiatrists about the basic concepts of nitrous oxide administration and pharmacology. Furthermore, common misconceptions about nitrous oxide will be discussed.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/jcp.0000000000000837

Cites

44 of 44 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Nitrous oxide inhibits NMDA currents in a dose-dependent manner.

    “Nitrous oxide inhibits NMDA currents in a dose-dependent manner, amongst other documented mechanisms [176]”

    From Ketamine in neuropsychiatric disorders: an update (2024) · cites this paper as [176]

    The 'Basic facts about nitrous oxide' section (page unavailable) describes nitrous oxide as a non-competitive NMDA-receptor antagonist, supporting the inhibition mechanism. It does not say that inhibition of NMDA currents is dose-dependent; searches for dose- or concentration-dependent NMDA-current inhibition found no such passage. (LLM, conf=0.87)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

1 of the 45 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Nagele, P., Zorumski, C. F., & Conway, C.
Affiliations
  • From the *Division of Clinical and Translational Research, Department of Anesthesiology, †Taylor Family Institute for Innovative Psychiatric Research, and ‡Department of Psychiatry, Washington University in St Louis, St Louis, MO.
  • Washington University in St. Louis (US)
Venue
Journal of Clinical Psychopharmacology
Published
2018-04
Volume
38
Issue
2
Pages
144-148
ISSN
  • 0271-0749 (ISSN-L)
  • 1533-712X
OpenAlex
W2789418706
Cited by
43
References
45
Citations by year
2026: 3 · 2025: 4 · 2024: 3 · 2023: 9 · 2022: 7 · 2021: 7 · 2020: 7 · 2019: 2 · 2018: 1
FWCI
0.50
Type
journal article
Language
en
Open access
Locations
  • Journal of Clinical Psychopharmacology (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • Bristol-Myers Squibb
  • Sage Therapeutics
  • Otsuka Pharmaceutical
  • Institute of Innovative Research, Tokyo Institute of Technology
  • National Institute of Mental Health (R21MH108901)
  • Taylor Family Institute for Innovative Psychiatric Research, Washington University School of Medicine in St. Louis
Topics
  • Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
  • Health Sciences › Medicine › Psychiatry and Mental health › Electroconvulsive Therapy Studies
  • Health Sciences › Medicine › Anesthesiology and Pain Medicine › Anesthesia and Sedative Agents
Keywords
nitrous oxide, mood disorders, treatment-resistant depression, rapid-acting antidepressants, regulatory guidelines
MeSH terms
Humans, Nitrous Oxide, Excitatory Amino Acid Antagonists, Mood Disorders

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review